Asosiy kontentga oʻtish
Maqola

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

Paul M. Ridkerthe Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USAMatt DevalarajaFlorian M.M. BaeresNovo Nordisk, Bagsvaerd, DenmarkMads D.M. EngelmannNovo Nordisk, Bagsvaerd, DenmarkG. Kees HovinghNovo Nordisk, Bagsvaerd, DenmarkMilana IvkovicNovo Nordisk, Bagsvaerd, DenmarkLarry LoDouglas KlingPablo E. PérgolaRenal Associates, San Antonio, TX, USADominic S. RajDivision of Kidney Diseases and Hypertension, George Washington University, Washington, DC, USAPeter LibbyBrigham and Women's HospitalMichael Davidson
2021en
ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba